ACAD vs PLTR · P/E 15, rev $576.0M vs P/E 584, rev $3.57B
ACADIA Pharmaceuticals Inc (ACAD) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the ACAD and PLTR stock pages for the full models.
Not investment advice.